Literature DB >> 11149662

The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire.

S Sarmer1, S Ergin, G Yavuzer.   

Abstract

This study was undertaken to translate and adapt the Fibromyalgia Impact Questionnaire (FIQ) into the Turkish language and investigate its validity and reliability for Turkish female fibromyalgia (FM) patients. After translation into Turkish, we administered the FIQ and Health Assessment Questionnaire (HAQ) to 51 women with fibromyalgia. As well as sociodemographic characteristics, the severity of relevant clinical symptoms, e.g., pain intensity, fatigue, and sleep disturbance, were assessed by visual analog scales. A tender point score (TPS) was calculated from tender points conducted by thumb palpation. Test-retest reliability, internal consistency, and concurrent and construct validities of FIQ were evaluated. Test-retest reliability and internal consistency were good at 0.81 and 0.72, respectively. Correlation between FIQ and HAQ scores was 0.43, which was low but statistically significant. Significant moderate correlations were obtained between the FIQ items and severity of clinical symptoms (0.63-0.77), except TPS, 0.31. The FIQ is a reliable and valid instrument for measuring functional disability in Turkish female FM patients.

Entities:  

Mesh:

Year:  2000        PMID: 11149662     DOI: 10.1007/s002960000077

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  91 in total

1.  The frequency of hypermobility and its relationship with clinical findings of fibromyalgia patients.

Authors:  O Faruk Sendur; Gulcan Gurer; Gulnur Tasci Bozbas
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

2.  Genital sympathetic skin responses in fibromyalgia syndrome.

Authors:  Ece Unlü; Umit Hidir Ulaş; Eda Gürçay; Reyhan Tuncay; Sezai Berber; Aytül Cakçi; Zeki Odabaşi
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

3.  SPA therapy in fibromyalgia: a randomised controlled clinic study.

Authors:  Arif Dönmez; M Zeki Karagülle; Nuran Tercan; Mustafa Dinler; Halim Işsever; Mine Karagülle; Mustafa Turan
Journal:  Rheumatol Int       Date:  2005-06-17       Impact factor: 2.631

4.  Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study.

Authors:  Omer Faruk Sendur; Yasemin Turan; Engin Tastaban; Cigdem Yenisey; Mukadder Serter
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

5.  Is balance exercise training as effective as aerobic exercise training in fibromyalgia syndrome?

Authors:  Neslihan Duruturk; Emine Handan Tuzun; Belde Culhaoglu
Journal:  Rheumatol Int       Date:  2014-10-22       Impact factor: 2.631

6.  Is There a Link Between Obstructive Sleep Apnea Syndrome and Fibromyalgia Syndrome?

Authors:  Handan İnönü Köseoğlu; Ahmet İnanır; Asiye Kanbay; Sevil Okan; Osman Demir; Osman Çeçen; Sema İnanır
Journal:  Turk Thorac J       Date:  2017-05-01

7.  The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial.

Authors:  Ilknur Saral; Dilsad Sindel; Sina Esmaeilzadeh; Hanife Ozlem Sertel-Berk; Aydan Oral
Journal:  Rheumatol Int       Date:  2016-04-07       Impact factor: 2.631

8.  Serum lipid profile in fibromyalgia women.

Authors:  Gulcan Gurer; Omer Faruk Sendur; Cavidan Ay
Journal:  Clin Rheumatol       Date:  2005-10-01       Impact factor: 2.980

9.  Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.

Authors:  Sema Haliloglu; Ayse Carlioglu; Derya Akdeniz; Yasar Karaaslan; Ali Kosar
Journal:  Rheumatol Int       Date:  2014-03-04       Impact factor: 2.631

10.  Real-life effectiveness of spa therapy in rheumatic and musculoskeletal diseases: a retrospective study of 819 patients.

Authors:  Mine Karagülle; Sinan Kardeş; Müfit Zeki Karagülle
Journal:  Int J Biometeorol       Date:  2017-05-30       Impact factor: 3.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.